These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2156886)

  • 41. Comparison of the effects of ouabain and brain natriuretic peptide in saline-loaded sheep.
    Pidgeon GB; Richards AM; Nicholls MG; Lewis LK; Yandle TG; Rademaker MT; Charles CJ; Bailey RR; Lynn KL
    Clin Exp Pharmacol Physiol; 1997 Nov; 24(11):807-13. PubMed ID: 9363361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study.
    Meeran K; O'Shea D; Upton PD; Small CJ; Ghatei MA; Byfield PH; Bloom SR
    J Clin Endocrinol Metab; 1997 Jan; 82(1):95-100. PubMed ID: 8989240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary immunoreactive brain natriuretic peptide in patients with renal disease.
    Totsune K; Takahashi K; Satoh F; Sone M; Ohneda M; Satoh C; Murakami O; Mouri T
    Regul Pept; 1996 Jul; 63(2-3):141-7. PubMed ID: 8837222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The endocrine basis of the cardio-renal axis: New perspectives regarding corin.
    Abassi Z; Hamo-Giladi DB; Kinaneh S; Heyman SN
    Physiol Rep; 2024 Jul; 12(13):e16105. PubMed ID: 38942727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B-Type Natriuretic Peptide (BNP) Revisited-Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
    Nishikimi T; Nakagawa Y
    Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac natriuretic peptides.
    Goetze JP; Bruneau BG; Ramos HR; Ogawa T; de Bold MK; de Bold AJ
    Nat Rev Cardiol; 2020 Nov; 17(11):698-717. PubMed ID: 32444692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BNP as a Major Player in the Heart-Kidney Connection.
    Okamoto R; Ali Y; Hashizume R; Suzuki N; Ito M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential role of dipeptidyl peptidase IV in the pathophysiology of heart failure.
    Salles TA; dos Santos L; Barauna VG; Girardi AC
    Int J Mol Sci; 2015 Feb; 16(2):4226-49. PubMed ID: 25690036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
    Potter LR; Yoder AR; Flora DR; Antos LK; Dickey DM
    Handb Exp Pharmacol; 2009; (191):341-66. PubMed ID: 19089336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig.
    Hermel M
    Inflammopharmacology; 1998; 6(2):159-78. PubMed ID: 17694372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nesiritide for acute decompensated heart failure: does the benefit justify the risk?
    Sackner-Bernstein J; Aaronson KD
    Curr Cardiol Rep; 2007 May; 9(3):187-93. PubMed ID: 17470331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure.
    Wang W; Ou Y; Shi Y
    Pharm Res; 2004 Nov; 21(11):2105-11. PubMed ID: 15587934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous vasodilator therapy in congestive heart failure.
    Moazemi K; Chana JS; Willard AM; Kocheril AG
    Drugs Aging; 2003; 20(7):485-508. PubMed ID: 12749747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery.
    Morimoto K; Mori T; Ishiguro S; Matsuda N; Hara Y; Kuroda H
    Surg Today; 1998; 28(1):23-9. PubMed ID: 9505313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain natriuretic peptide predicts mortality in the elderly.
    Wallén T; Landahl S; Hedner T; Nakao K; Saito Y
    Heart; 1997 Mar; 77(3):264-7. PubMed ID: 9093047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.
    Tan AC; Russel FG; Thien T; Benraad TJ
    Clin Pharmacokinet; 1993 Jan; 24(1):28-45. PubMed ID: 8448971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain natriuretic peptide and fluid volume homeostasis--studies during cardiopulmonary bypass surgery.
    Ationu A; Burch M; Elliott M; Carter N
    Clin Auton Res; 1993 Aug; 3(4):275-80. PubMed ID: 8292884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases.
    Koller KJ; de Sauvage FJ; Lowe DG; Goeddel DV
    Mol Cell Biol; 1992 Jun; 12(6):2581-90. PubMed ID: 1350322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain natriuretic peptide administered to man: actions and metabolism.
    McGregor A; Richards M; Espiner E; Yandle T; Ikram H
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1103-7. PubMed ID: 2156886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
    Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.